Article
Highlights in Diabetes and Metabolism From ASN 2022
- Author:
- Carol Wysham, MD
Publish date: November 28, 2022
From ASN 2022, Dr Carol Wysham highlights data on glucose-lowering drugs in patients with T2D, including empagliflozin and semaglutide, and a link...
Article
Key Data on Comorbidities in Type 2 Diabetes From EASD 2022
- Author:
- Carol Wysham, MD
Publish date: October 6, 2022
From EASD 2022, Dr Carol Wysham reports on advancing research for patients with type 2 diabetes and comorbidities, including nonalcoholic fatty...